Evidence suggests that Activin A can regulate the malignant phenotype of tumor cells through signaling pathways such as SMAD, PI3K-AKT, and ERK [16], and follistatin (FST) is its specific antagonist [17]. This evidence concerns the gene FST and neoplasm.